Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis
Summary Objective The usefulness of any questionnaire in clinical management and research trials depends on its ability to indicate a likelihood of treatment success during follow-up. The Minimal Clinically Important Difference (MCID) reflects a clinically relevant change score. The aim of this stud...
Gespeichert in:
| Veröffentlicht in: | Respiratory medicine 2011-09, Vol.105 (9), p.1388-1395 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1395 |
|---|---|
| container_issue | 9 |
| container_start_page | 1388 |
| container_title | Respiratory medicine |
| container_volume | 105 |
| creator | de Kleijn, Willemien P.E De Vries, Jolanda Wijnen, Petal A.H.M Drent, Marjolein |
| description | Summary Objective The usefulness of any questionnaire in clinical management and research trials depends on its ability to indicate a likelihood of treatment success during follow-up. The Minimal Clinically Important Difference (MCID) reflects a clinically relevant change score. The aim of this study was to estimate the MCID for the Fatigue Assessment Scale (FAS) in patients with sarcoidosis. Methods Outpatients ( n = 321) of the ild care team of the Department of Respiratory Medicine of the Maastricht University Medical Centre, The Netherlands, participated in this prospective follow-up study. Anchor-based and distribution-based methods were used to estimate the MCID. Based on the anchor Physical Quality of Life, a Receiver Operating Characteristic (ROC) was obtained. The distribution-based methods consisted of the Effect Size and Standard Error Measurement (SEM). Results The anchor-based MCID found with ROC was 3.5. The distribution-based methods showed that the corresponding change scores in the FAS for a small effect was 4.2. The SEM criterion was 3.6 points change in the FAS. Conclusions Based on the anchor-based and distribution-based methods, the MCID is a 4-point difference on the FAS. This MCID can be used in the follow-up of fatigue (FAS) in clinical trials and in the management of individual sarcoidosis cases. |
| doi_str_mv | 10.1016/j.rmed.2011.05.004 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_878031737</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0954611111001673</els_id><sourcerecordid>878031737</sourcerecordid><originalsourceid>FETCH-LOGICAL-c611t-3a31474dc5395ef5eae900fe26b5adb23f61ba31878756b18cb138fb230af8623</originalsourceid><addsrcrecordid>eNp9kk-LFDEQxYMo7jj6BTxIg4jrYdqqTtLdAyIsi6vCiofVi5eQTlc0Y_-ZTfUI8-1NMzMs7GFPCdTvFVXvlRAvEXIELN9v8thTmxeAmIPOAdQjsUAti5WEUj0WC1hrtSoR8Uw8Y94AwFopeCrOCqwSrWAhfn0LQ-htl527Lv2c7br9uyz02zFOdpiyNnhPkQZHnPkxZtMfyq7sFH7vKLtgJuaeEnaThJSFIWMb3RjakQM_F0-87ZheHN-l-Hn16cfll9X1989fLy-uVy6NNq2klagq1Tot15q8JktrAE9F2WjbNoX0JTaJqau60mWDtWtQ1j4VwPq6LORSvD303cbxdkc8mT6wo66zA407NkkIEitZJfL8QRJRIxTrqiwT-voeuhl3cUh7GASpUSpV1YkqDpSLI3Mkb7YxuRn3CTJzRmZj5ozMnJEBbZLrSfTq2HrXzLWT5BRKAt4cAcvJVx_t4ALfcUrWskwjLMWHA0fJ3X-BomEX5qjaEMlNph3Dw3N8vCc_ncBf2hPf7Wu4MGBu5muajwkRUsdKyv9JecKh</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1035134478</pqid></control><display><type>article</type><title>Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>de Kleijn, Willemien P.E ; De Vries, Jolanda ; Wijnen, Petal A.H.M ; Drent, Marjolein</creator><creatorcontrib>de Kleijn, Willemien P.E ; De Vries, Jolanda ; Wijnen, Petal A.H.M ; Drent, Marjolein</creatorcontrib><description>Summary Objective The usefulness of any questionnaire in clinical management and research trials depends on its ability to indicate a likelihood of treatment success during follow-up. The Minimal Clinically Important Difference (MCID) reflects a clinically relevant change score. The aim of this study was to estimate the MCID for the Fatigue Assessment Scale (FAS) in patients with sarcoidosis. Methods Outpatients ( n = 321) of the ild care team of the Department of Respiratory Medicine of the Maastricht University Medical Centre, The Netherlands, participated in this prospective follow-up study. Anchor-based and distribution-based methods were used to estimate the MCID. Based on the anchor Physical Quality of Life, a Receiver Operating Characteristic (ROC) was obtained. The distribution-based methods consisted of the Effect Size and Standard Error Measurement (SEM). Results The anchor-based MCID found with ROC was 3.5. The distribution-based methods showed that the corresponding change scores in the FAS for a small effect was 4.2. The SEM criterion was 3.6 points change in the FAS. Conclusions Based on the anchor-based and distribution-based methods, the MCID is a 4-point difference on the FAS. This MCID can be used in the follow-up of fatigue (FAS) in clinical trials and in the management of individual sarcoidosis cases.</description><identifier>ISSN: 0954-6111</identifier><identifier>EISSN: 1532-3064</identifier><identifier>DOI: 10.1016/j.rmed.2011.05.004</identifier><identifier>PMID: 21700440</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Activities of Daily Living ; Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Clinical medicine ; Clinical trials ; Disability Evaluation ; Fatigue ; Fatigue - diagnosis ; Fatigue - etiology ; Fatigue - psychology ; Fatigue Assessment Scale ; Female ; Follow-Up Studies ; Humans ; Likert scale ; Medical sciences ; Methods ; Middle Aged ; Minimal clinically important difference ; Netherlands ; Pneumology ; Prospective Studies ; Pulmonary/Respiratory ; Quality of life ; Quality of Life - psychology ; Questionnaires ; Sarcoidosis ; Sarcoidosis, Pulmonary - complications ; Sarcoidosis, Pulmonary - diagnosis ; Sarcoidosis, Pulmonary - psychology ; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis ; Severity of Illness Index ; Studies ; Surveys and Questionnaires - standards ; Treatment Outcome ; Validity</subject><ispartof>Respiratory medicine, 2011-09, Vol.105 (9), p.1388-1395</ispartof><rights>Elsevier Ltd</rights><rights>2011 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c611t-3a31474dc5395ef5eae900fe26b5adb23f61ba31878756b18cb138fb230af8623</citedby><cites>FETCH-LOGICAL-c611t-3a31474dc5395ef5eae900fe26b5adb23f61ba31878756b18cb138fb230af8623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.rmed.2011.05.004$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24383651$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21700440$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Kleijn, Willemien P.E</creatorcontrib><creatorcontrib>De Vries, Jolanda</creatorcontrib><creatorcontrib>Wijnen, Petal A.H.M</creatorcontrib><creatorcontrib>Drent, Marjolein</creatorcontrib><title>Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis</title><title>Respiratory medicine</title><addtitle>Respir Med</addtitle><description>Summary Objective The usefulness of any questionnaire in clinical management and research trials depends on its ability to indicate a likelihood of treatment success during follow-up. The Minimal Clinically Important Difference (MCID) reflects a clinically relevant change score. The aim of this study was to estimate the MCID for the Fatigue Assessment Scale (FAS) in patients with sarcoidosis. Methods Outpatients ( n = 321) of the ild care team of the Department of Respiratory Medicine of the Maastricht University Medical Centre, The Netherlands, participated in this prospective follow-up study. Anchor-based and distribution-based methods were used to estimate the MCID. Based on the anchor Physical Quality of Life, a Receiver Operating Characteristic (ROC) was obtained. The distribution-based methods consisted of the Effect Size and Standard Error Measurement (SEM). Results The anchor-based MCID found with ROC was 3.5. The distribution-based methods showed that the corresponding change scores in the FAS for a small effect was 4.2. The SEM criterion was 3.6 points change in the FAS. Conclusions Based on the anchor-based and distribution-based methods, the MCID is a 4-point difference on the FAS. This MCID can be used in the follow-up of fatigue (FAS) in clinical trials and in the management of individual sarcoidosis cases.</description><subject>Activities of Daily Living</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Clinical medicine</subject><subject>Clinical trials</subject><subject>Disability Evaluation</subject><subject>Fatigue</subject><subject>Fatigue - diagnosis</subject><subject>Fatigue - etiology</subject><subject>Fatigue - psychology</subject><subject>Fatigue Assessment Scale</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Likert scale</subject><subject>Medical sciences</subject><subject>Methods</subject><subject>Middle Aged</subject><subject>Minimal clinically important difference</subject><subject>Netherlands</subject><subject>Pneumology</subject><subject>Prospective Studies</subject><subject>Pulmonary/Respiratory</subject><subject>Quality of life</subject><subject>Quality of Life - psychology</subject><subject>Questionnaires</subject><subject>Sarcoidosis</subject><subject>Sarcoidosis, Pulmonary - complications</subject><subject>Sarcoidosis, Pulmonary - diagnosis</subject><subject>Sarcoidosis, Pulmonary - psychology</subject><subject>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</subject><subject>Severity of Illness Index</subject><subject>Studies</subject><subject>Surveys and Questionnaires - standards</subject><subject>Treatment Outcome</subject><subject>Validity</subject><issn>0954-6111</issn><issn>1532-3064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kk-LFDEQxYMo7jj6BTxIg4jrYdqqTtLdAyIsi6vCiofVi5eQTlc0Y_-ZTfUI8-1NMzMs7GFPCdTvFVXvlRAvEXIELN9v8thTmxeAmIPOAdQjsUAti5WEUj0WC1hrtSoR8Uw8Y94AwFopeCrOCqwSrWAhfn0LQ-htl527Lv2c7br9uyz02zFOdpiyNnhPkQZHnPkxZtMfyq7sFH7vKLtgJuaeEnaThJSFIWMb3RjakQM_F0-87ZheHN-l-Hn16cfll9X1989fLy-uVy6NNq2klagq1Tot15q8JktrAE9F2WjbNoX0JTaJqau60mWDtWtQ1j4VwPq6LORSvD303cbxdkc8mT6wo66zA407NkkIEitZJfL8QRJRIxTrqiwT-voeuhl3cUh7GASpUSpV1YkqDpSLI3Mkb7YxuRn3CTJzRmZj5ozMnJEBbZLrSfTq2HrXzLWT5BRKAt4cAcvJVx_t4ALfcUrWskwjLMWHA0fJ3X-BomEX5qjaEMlNph3Dw3N8vCc_ncBf2hPf7Wu4MGBu5muajwkRUsdKyv9JecKh</recordid><startdate>20110901</startdate><enddate>20110901</enddate><creator>de Kleijn, Willemien P.E</creator><creator>De Vries, Jolanda</creator><creator>Wijnen, Petal A.H.M</creator><creator>Drent, Marjolein</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>ASE</scope><scope>FPQ</scope><scope>H94</scope><scope>K6X</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20110901</creationdate><title>Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis</title><author>de Kleijn, Willemien P.E ; De Vries, Jolanda ; Wijnen, Petal A.H.M ; Drent, Marjolein</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c611t-3a31474dc5395ef5eae900fe26b5adb23f61ba31878756b18cb138fb230af8623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Activities of Daily Living</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Clinical medicine</topic><topic>Clinical trials</topic><topic>Disability Evaluation</topic><topic>Fatigue</topic><topic>Fatigue - diagnosis</topic><topic>Fatigue - etiology</topic><topic>Fatigue - psychology</topic><topic>Fatigue Assessment Scale</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Likert scale</topic><topic>Medical sciences</topic><topic>Methods</topic><topic>Middle Aged</topic><topic>Minimal clinically important difference</topic><topic>Netherlands</topic><topic>Pneumology</topic><topic>Prospective Studies</topic><topic>Pulmonary/Respiratory</topic><topic>Quality of life</topic><topic>Quality of Life - psychology</topic><topic>Questionnaires</topic><topic>Sarcoidosis</topic><topic>Sarcoidosis, Pulmonary - complications</topic><topic>Sarcoidosis, Pulmonary - diagnosis</topic><topic>Sarcoidosis, Pulmonary - psychology</topic><topic>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</topic><topic>Severity of Illness Index</topic><topic>Studies</topic><topic>Surveys and Questionnaires - standards</topic><topic>Treatment Outcome</topic><topic>Validity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Kleijn, Willemien P.E</creatorcontrib><creatorcontrib>De Vries, Jolanda</creatorcontrib><creatorcontrib>Wijnen, Petal A.H.M</creatorcontrib><creatorcontrib>Drent, Marjolein</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Respiratory medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Kleijn, Willemien P.E</au><au>De Vries, Jolanda</au><au>Wijnen, Petal A.H.M</au><au>Drent, Marjolein</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis</atitle><jtitle>Respiratory medicine</jtitle><addtitle>Respir Med</addtitle><date>2011-09-01</date><risdate>2011</risdate><volume>105</volume><issue>9</issue><spage>1388</spage><epage>1395</epage><pages>1388-1395</pages><issn>0954-6111</issn><eissn>1532-3064</eissn><abstract>Summary Objective The usefulness of any questionnaire in clinical management and research trials depends on its ability to indicate a likelihood of treatment success during follow-up. The Minimal Clinically Important Difference (MCID) reflects a clinically relevant change score. The aim of this study was to estimate the MCID for the Fatigue Assessment Scale (FAS) in patients with sarcoidosis. Methods Outpatients ( n = 321) of the ild care team of the Department of Respiratory Medicine of the Maastricht University Medical Centre, The Netherlands, participated in this prospective follow-up study. Anchor-based and distribution-based methods were used to estimate the MCID. Based on the anchor Physical Quality of Life, a Receiver Operating Characteristic (ROC) was obtained. The distribution-based methods consisted of the Effect Size and Standard Error Measurement (SEM). Results The anchor-based MCID found with ROC was 3.5. The distribution-based methods showed that the corresponding change scores in the FAS for a small effect was 4.2. The SEM criterion was 3.6 points change in the FAS. Conclusions Based on the anchor-based and distribution-based methods, the MCID is a 4-point difference on the FAS. This MCID can be used in the follow-up of fatigue (FAS) in clinical trials and in the management of individual sarcoidosis cases.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>21700440</pmid><doi>10.1016/j.rmed.2011.05.004</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0954-6111 |
| ispartof | Respiratory medicine, 2011-09, Vol.105 (9), p.1388-1395 |
| issn | 0954-6111 1532-3064 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_878031737 |
| source | MEDLINE; Access via ScienceDirect (Elsevier); EZB-FREE-00999 freely available EZB journals |
| subjects | Activities of Daily Living Adult Aged Aged, 80 and over Biological and medical sciences Clinical medicine Clinical trials Disability Evaluation Fatigue Fatigue - diagnosis Fatigue - etiology Fatigue - psychology Fatigue Assessment Scale Female Follow-Up Studies Humans Likert scale Medical sciences Methods Middle Aged Minimal clinically important difference Netherlands Pneumology Prospective Studies Pulmonary/Respiratory Quality of life Quality of Life - psychology Questionnaires Sarcoidosis Sarcoidosis, Pulmonary - complications Sarcoidosis, Pulmonary - diagnosis Sarcoidosis, Pulmonary - psychology Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Severity of Illness Index Studies Surveys and Questionnaires - standards Treatment Outcome Validity |
| title | Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T16%3A34%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Minimal%20(clinically)%20important%20differences%20for%20the%20Fatigue%20Assessment%20Scale%20in%20sarcoidosis&rft.jtitle=Respiratory%20medicine&rft.au=de%20Kleijn,%20Willemien%20P.E&rft.date=2011-09-01&rft.volume=105&rft.issue=9&rft.spage=1388&rft.epage=1395&rft.pages=1388-1395&rft.issn=0954-6111&rft.eissn=1532-3064&rft_id=info:doi/10.1016/j.rmed.2011.05.004&rft_dat=%3Cproquest_cross%3E878031737%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1035134478&rft_id=info:pmid/21700440&rft_els_id=S0954611111001673&rfr_iscdi=true |